DaVita Other Long-Term Assets 2010-2025 | DVA

DaVita other long-term assets from 2010 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • DaVita other long-term assets for the quarter ending March 31, 2025 were $0.239B, a 8.96% decline year-over-year.
  • DaVita other long-term assets for 2024 were $0.262B, a 3.51% decline from 2023.
  • DaVita other long-term assets for 2023 were $0.271B, a 14.05% decline from 2022.
  • DaVita other long-term assets for 2022 were $0.316B, a 130.9% increase from 2021.
DaVita Annual Other Long-Term Assets
(Millions of US $)
2024 $262
2023 $271
2022 $316
2021 $137
2020 $80
2019 $116
2018 $72
2017 $47
2016 $5,286
2015 $74
2014 $77
2013 $80
2012 $80
2011 $34
2010 $32
2009 $33
DaVita Quarterly Other Long-Term Assets
(Millions of US $)
2025-03-31 $239
2024-12-31 $262
2024-09-30 $219
2024-06-30 $240
2024-03-31 $262
2023-12-31 $271
2023-09-30 $302
2023-06-30 $314
2023-03-31 $291
2022-12-31 $316
2022-09-30 $308
2022-06-30 $258
2022-03-31 $185
2021-12-31 $137
2021-09-30 $101
2021-06-30 $95
2021-03-31 $91
2020-12-31 $80
2020-09-30 $96
2020-06-30 $93
2020-03-31 $94
2019-12-31 $116
2019-09-30 $115
2019-06-30 $97
2019-03-31 $74
2018-12-31 $72
2018-09-30 $77
2018-06-30 $59
2018-03-31 $52
2017-12-31 $47
2017-09-30 $62
2017-06-30 $60
2017-03-31 $43
2016-12-31 $5,286
2016-09-30 $43
2016-06-30 $64
2016-03-31 $66
2015-12-31 $74
2015-09-30 $62
2015-06-30 $122
2015-03-31 $68
2014-12-31 $77
2014-09-30 $67
2014-06-30 $66
2014-03-31 $77
2013-12-31 $80
2013-09-30 $80
2013-06-30 $98
2013-03-31 $87
2012-12-31 $80
2012-09-30 $1,299
2012-06-30 $30
2012-03-31 $30
2011-12-31 $34
2011-09-30 $32
2011-06-30 $35
2011-03-31 $41
2010-12-31 $32
2010-09-30 $32
2010-06-30 $33
2010-03-31 $33
2009-12-31 $33
2009-09-30 $34
2009-06-30 $44
2009-03-31 $46
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $10.658B $12.816B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.633B 18.36
Encompass Health (EHC) United States $11.089B 23.51
Elanco Animal Health (ELAN) United States $7.340B 15.72
Chemed (CHE) United States $6.602B 20.75
Option Care Health (OPCH) United States $4.827B 21.52
RadNet (RDNT) United States $4.313B 273.76
Amedisys (AMED) United States $3.199B 21.51
Addus HomeCare (ADUS) United States $1.969B 21.62
LifeStance Health (LFST) United States $1.641B 0.00
Astrana Health (ASTH) United States $1.270B 31.46
U.S Physical Therapy (USPH) United States $1.124B 29.02
Pennant (PNTG) United States $0.808B 29.66
Aveanna Healthcare Holdings (AVAH) United States $0.773B 44.00
Atai Life Sciences (ATAI) Germany $0.647B 0.00
Daxor (DXR) United States $0.044B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00